1. Introduction
Pediatric facial wounds are common because the head and face are frequently involved in childhood trauma [
1,
2,
3,
4]. Most facial lacerations heal well, but infection, periorbital cellulitis, scarring, and other complications can require additional treatment [
5,
6,
7,
8,
9,
10]. Published descriptions consistently identify the perioral, periorbital, nasal, and frontal regions as common sites [
3,
11,
12,
13,
14,
15]. However, site-specific infection risk is difficult to infer because most cohorts do not combine a denominator-defined population with detailed information on the mechanism, depth, timing, and initial wound management.
Evidence supporting antibiotic prophylaxis for traumatic facial wounds remains heterogeneous. Contemporary recommendations emphasize the wound mechanism, tissue damage, contamination, bite exposure, patient factors, and established clinical infection rather than anatomical site alone [
16,
17,
18,
19]. Pediatric evidence is concentrated on animal bites [
20,
21,
22,
23,
24,
25,
26], whereas infected or delayed facial wounds from other mechanisms are less well characterized. Host wound-healing responses and facial skin microbial communities vary with age and context [
27,
28]. Emerging biomaterial research has expanded wound-dressing functions from passive coverage to antimicrobial delivery, sensing, and healing assessment, while experimental immunoregulatory hydrogels have targeted oxygenation and reactive oxygen species in chronic wounds [
29,
30]. These technologies are not directly validated for acute pediatric facial wounds, but they underscore the importance of precise wound characterization when interpreting clinical management.
The objective of this study was to characterize the anatomy, mechanism, wound type, size and depth, initial closure, antibiotic treatment, microbiology, follow-up, and documented complications of pediatric facial wounds with record-documented infection or delayed/non-recent presentation. We additionally described dog bites and oral/intraoral wounds separately and explored selected associations with record-defined group membership.
2. Materials and Methods
This retrospective, single-center case series study was conducted at the Department of Trauma Surgery, Medical University of Vienna. The study period extended from 1 January 2000 through 31 December 2024. The Ethics Committee of the Medical University of Vienna approved the study (1133/2025) in accordance with the Declaration of Helsinki.
Potentially eligible records were identified in the hospital electronic information system (AKIM) by free-text searching combinations of concepts for facial location, wound type, infection or inflammation, and delayed or non-recent presentation. A separate broad administrative count identified 24,877 pediatric facial-wound presentations among patients aged 0–17 years during 2000–2024. The targeted free-text search was not validated against this denominator, and its sensitivity may have varied over time. All retrieved records were manually reviewed. Inclusion required age younger than 18 years, a facial soft-tissue wound, and classification into one of the two mutually exclusive source-record groups shown in
Table 1. Records were excluded when the wound was outside the facial region, neither operational group was supported by the documentation, or information was insufficient for classification.
The source spreadsheet contained 92 screened patient records. Three lacked sufficient information for operational classification, leaving 89 patients for analysis; each patient contributed one encounter and one wound record. The variables included age, sex, injury type, bite mechanism, documented infection status, facial region, wound size and depth, calendar-day interval to presentation, pre-presentation antibiotics, initial wound closure and closure method, antibiotic treatment after presentation, hospital admission, surgery, microbiological testing, follow-up, and complications. Wound size was documented as length in mm and wound depth was re-abstracted from the narrative clinical documentation and categorized according to the deepest documented tissue layer involved: superficial, when the wound was limited to the skin/dermis without documented subcutaneous extension; subcutaneous, when extension into subcutaneous tissue was documented without muscle involvement; intramuscular, when the wound extended into or through muscle; and unknown, when the available documentation was insufficient to assign one of these categories. Perioral records were re-reviewed to distinguish external, intraoral, and combined wounds; vermilion involvement; and intraoral self-bite versus laceration. The source comorbidity field combined chronic conditions, allergies, and trauma-associated diagnoses and was excluded. Macroscopic contamination and foreign-body status were excluded because ascertainment was incomplete. Anatomical coding was reconciled with diagnosis text: one nonstandard code with an explicit buccal diagnosis was classified as buccal, and one combined oral/buccal entry was retained as a combined perioral category.
Statistical Analysis
Categorical variables are presented as n/N (%) using the number of records with an interpretable value as the denominator; missing or unclear values were not recoded as no. Percentages were rounded to whole numbers because of the small cohort, except the cohort’s proportion of all facial-wound presentations, which was retained to two decimal places to avoid rounding to zero. Continuous variables are summarized by their median and interquartile range (IQR), with the range where informative. Frontal and orbital wounds were combined as forehead/periorbital, while oral, buccal, and combined oral/buccal wounds were combined as perioral for aggregate analyses. Exploratory associations between record-defined infection status and region, bite mechanism, wound depth, initial closure, admission, and post-presentation antibiotics were assessed with two-sided Fisher exact tests. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using the standard logit method; tests were unadjusted for multiple comparisons and are hypothesis-generating. Multivariable regression was not performed because of sparse cells, quasi-separation, and the different record-based group definitions. No formal sample-size calculation was performed; all eligible records identified during the 25-year period were included. A post hoc descriptive sensitivity analysis divided the period into 2000–2007, 2008–2015, and 2016–2024. Analyses were performed using Microsoft Excel (version 16.90.2) and independently checked against the patient-level spreadsheet. OpenAI ChatGPT (GPT-5; accessed 23. August 2026) assisted with code drafting for data verification. All classifications and calculations were independently verified by the authors.
3. Results
3.1. Study Population and Cohort Characteristics
The 89 included patients comprised 58 boys (65%) and 31 girls (35%). Their median age was 4 years (IQR, 2–8; range, 1–17). The source record coded 61 patients (69%) as clinically infected and 28 (31%) as delayed/non-recent without record-coded infection. These 89 selected cases represented 0.36% of the 24,877 pediatric facial-wound presentations recorded during the same period. This proportion describes cohort selection and should not be interpreted as infection incidence because the targeted search was not validated against the denominator. No standardized chronic-comorbidity variable was available.
Lacerations were the most frequent injury type (63/89, 71%), followed by bites (20/89, 22%), stab wounds (4/89, 4%), one cut, and one excoriation. The bite wounds comprised eight dog bites (9%) and 12 human bites (13%).
Perioral wounds were the most frequent regional category (46/89, 52%): 29 oral, 16 buccal, and one combined oral/buccal wound. Forehead/periorbital wounds accounted for 34/89 (38%): 18 frontal and 16 orbital. The remaining locations were chin (n = 5), auricular (n = 2), nasal (n = 1), and other (n = 1).
3.2. Management, Follow-Up, and Missingness
The median calendar-day interval from injury to presentation was 2 days (IQR, 1–3; range, 0–90). Follow-up was scheduled or required in 41/87 evaluable records (47%); two records were unclear. Admission was documented in 28/87 (32%), surgery in 8/88 (9%), microbiological testing in 10/88 (11%), pre-presentation antibiotics in 5/88 (6%), and post-presentation antibiotics in 53/86 (62%) (
Table 2). Among the 53 records with post-presentation treatment, a regimen containing amoxicillin–clavulanate was documented in 44, another regimen was documented in four, and the agent was unavailable in five. The route was recoverable in 34/53 records: combined intravenous and oral therapy in 23, oral therapy alone in nine, and intravenous therapy alone in two; the route was unclear in 19. The duration and treatment indication were not consistently recoverable. Five complications were documented among 84 evaluable records (6%); five had unclear status.
3.3. Record-Coded Clinically Infected Wounds
The record-coded clinically infected group included 61 patients. Their median age was 4 years (IQR, 2–9; range, 1–17); 38 (62%) were boys and 23 (38%) were girls.
The injury types were laceration (42/61, 69%), dog bite (8/61, 13%), human bite (8/61, 13%), and stab wound (3/61, 5%).
Forehead/periorbital wounds accounted for 27/61 (44%; frontal n = 16, orbital n = 11) and perioral wounds for 27/61 (44%; oral n = 13, buccal n = 14). The other locations were chin (n = 5), auricular (n = 1), and other (n = 1).
Among the evaluable records, admission was documented in 26/59 (44%), surgery in 8/60 (13%), and microbiological testing in 9/60 (15%).
Pre-presentation antibiotic therapy was documented in 5/60 (8%) evaluable records and post-presentation treatment in 48/58 (83%). A regimen containing amoxicillin–clavulanate was documented in 41/48 treated records.
Five complications were documented among 56 infected-group records with interpretable status (9%); status was unclear in five. Four involved forehead/periorbital wounds and one involved the chin. The small number of events precluded a reliable complication model.
3.4. Delayed/Non-Recent Wounds Without Record-Coded Infection
The delayed/non-recent group included 28 patients. Their median age was 4 years (IQR, 2–7.25; range, 1–17); 20 (71%) were boys and eight (29%) were girls.
The injury types were laceration (21/28, 75%), human bite (4/28, 14%), stab wound (1/28, 4%), cut (1/28, 4%), and excoriation (1/28, 4%). No dog bite was present in this group.
Perioral wounds accounted for 19/28 (68%; oral n = 16, buccal n = 2, combined oral/buccal n = 1) and forehead/periorbital wounds for 7/28 (25%; frontal n = 2, orbital n = 5). One auricular and one nasal wound completed the distribution.
Admission was documented in 2/28 records (7%); no surgery was documented. Complication status was interpretable in all 28 records, and no complication was documented.
No pre-presentation antibiotic use was documented. Post-presentation antibiotics were documented in 5/28 records (18%), including a regimen containing amoxicillin–clavulanate in three.
Microbiological testing was documented in 1/28 delayed/non-recent records (4%) and in 10/88 evaluable records overall (11%). Wound swabbing was documented in all 10 tested records, with additional bacteriology coding in five. Organisms, available resistance profiles, and recorded antibiotic concordance are presented in
Supplementary Table S1.
3.5. Group-Wise Descriptive Findings
The operational groups differed in terms of injury mix, anatomy, and management (
Table 3). Boys accounted for 62% of the infected group and 71% of the delayed/non-recent group. Bites accounted for 26% and 14%, respectively; all eight dog bites were in the infected group.
Table 3 summarizes injury, anatomical, and management variables within each operational group.
Forehead/periorbital wounds comprised 44% of infected-group records and 25% of delayed/non-recent records. Perioral wounds comprised 44% and 68%, respectively.
Post-presentation antibiotics and hospital admission were documented more frequently in the infected group. Variable-specific denominators account for missing values.
3.6. Expanded Wound Characterization and Exploratory Findings
The wound depth was superficial in 36/89 records (40%), subcutaneous in 35/89 (39%), intramuscular in 15/89 (17%), and unknown in 3/89 (3%). Among records with known depth, subcutaneous or intramuscular wounds occurred in 43/59 infected-group records (73%) and 7/27 delayed/non-recent records (26%). Initial closure was documented in 22/89 records (25%): 13 sutures, six Steri-Strips, two other techniques, and one tissue adhesive. The closure frequency was 16/61 (26%) in the infected group and 6/28 (21%) in the delayed/non-recent group.
Among the 46 perioral wounds, external involvement was documented in 22/40 evaluable records (55%), intraoral involvement in 17/40 (43%), and both in 1/40 (3%); six were not classifiable. Vermilion involvement was documented in 12/46 (26%). Among 34 perioral records with a classifiable intraoral mechanism, 20 (59%) were self-bite wounds and 14 (41%) were lacerations. These variables distinguish oral mucosal injury from external lip or buccal injury rather than treating all perioral wounds as biologically equivalent.
In exploratory two-sided Fisher exact tests, infected-group membership was associated with subcutaneous/intramuscular versus superficial depth (OR 7.68, 95% CI 2.73–21.61;
p < 0.001), admission (OR 10.24, 95% CI 2.22–47.17;
p < 0.001), and post-presentation antibiotics (OR 22.08, 95% CI 6.76–72.07;
p < 0.001). Perioral location was less frequent in the infected group (OR 0.38, 95% CI 0.15–0.96;
p = 0.043). Associations with forehead/periorbital location, any bite mechanism, dog bite, and initial closure were not statistically significant (
Table 4). These unadjusted analyses describe record-defined group membership and do not establish infection risk or treatment effects.
The median wound size was 10 mm (IQR, 5–15) in both groups; several larger wounds in the infected group accounted for its wider range.
3.7. Dog-Bite and Perioral Subgroup Findings
All eight dog-bite wounds were in the record-coded infected group. Six were buccal and two were coded as other/nonstandard facial sites. One was superficial, three were subcutaneous, and four were intramuscular. None had been initially closed. Pre-presentation antibiotic status was evaluable in seven dog-bite records (one yes and six no); post-presentation treatment was documented in 5/7, admission in 4/7, surgery in 1/7, and microbiological testing in 1/7. Complication status was evaluable and negative in 7/7; one transferred patient had unavailable subsequent outcome data.
Among the 12 human-bite wounds, three had been initially closed (two with Steri-Strips and one with sutures); none received pre-presentation antibiotics. Because all dog-bite wounds belonged to the infected group and none had been initially closed, this dataset could not be used to compare infection outcomes after immediate versus delayed dog-bite closure.
3.8. Exploratory Exact Analyses
Table 4 presents the prespecified exploratory comparisons requested during peer review. Effect estimates refer to odds of membership in the record-coded infected group rather than population infection risk.
3.9. Post Hoc Sensitivity Analysis by Calendar Era
Case composition and management varied across the study period. Records coded as infected accounted for 29/30 (97%) in 2000–2007, 15/34 (44%) in 2008–2015, and 17/25 (68%) in 2016–2024. Post-presentation antibiotic treatment, admission, and surgery also varied (
Table 5). Surgery declined from 6/29 (21%) in 2000–2007 to 2/34 (6%) in 2008–2015 and 0/25 in 2016–2024. These post hoc findings are descriptive and were not tested inferentially.
4. Discussion
This case series describes 89 selected pediatric facial-wound records with documented clinical infection or delayed/non-recent presentation, representing 0.36% of the 24,877 pediatric facial-wound presentations recorded at the center during the same period. The expanded analysis distinguishes dog from human bites, external from intraoral wounds, and superficial from subcutaneous or intramuscular wounds. The perioral region was the most common wound site, and management intensity was greater in the infected group.
Forehead/periorbital and perioral wounds showed different distributions across the operational groups. The exploratory analyses suggested lower odds of infected-group membership for perioral wounds and higher odds, although imprecisely estimated, for forehead/periorbital wounds. These findings cannot be interpreted as site-specific infection risk because the denominator by anatomical site and a representative noninfected comparison cohort were unavailable.
The median wound size and IQR were identical in both groups (10 mm; IQR, 5–15), although several larger wounds in the infected group widened its range. This pattern indicates substantial overlap in wound size between groups, whereas subcutaneous or intramuscular wounds were more frequent in the infected group. Depth is clinically relevant to tissue damage and contamination, but it was retrospectively abstracted from narrative documentation rather than measured using a standardized protocol. The observed association may therefore reflect documentation and referral severity as well as biology.
Post-presentation antibiotics and admission were strongly associated with infected-group membership, as expected when clinicians intensify treatment for established infection. These associations do not show prophylactic efficacy and are vulnerable to confounding by indication. The agent and route could be partly reconstructed, but the duration, treatment indication, and timing relative to closure were inconsistent. Initial closure was not associated with group membership, and none of the eight dog-bite wounds had been initially closed; a comparison of immediate versus delayed closure after dog bite was therefore not possible.
Microbiological testing was selective and documented in only 10/88 evaluable records. The small, clinician-selected subset and incomplete susceptibility data preclude pathogen prevalence estimates or conclusions about comparative antibiotic effectiveness.
The post hoc era analysis revealed substantial temporal heterogeneity, including a decline in surgery from 21% in 2000–2007 to 0% in 2016–2024. This could reflect changing case mix or severity, evolving referral thresholds, greater ambulatory management, antibiotic stewardship, different surgeons and services, and changes in electronic documentation and search sensitivity. Surgeon identifiers were not consistently available, and the small number of operations across many clinicians precluded surgeon-level outcome analysis. Calendar-era findings should therefore not be interpreted as evidence that one period’s management was superior.
Additional limitations include the retrospective single-center design, unvalidated search strategy, nonstandardized classification, variable-specific missing data, and incomplete or inconsistently recorded follow-up. The wound depth and initial treatment were reconstructed from clinical notes and were not recorded using uniform prospective definitions. The surgeon’s identity, exact closure timing, debridement details, treatment indication, route, and antibiotic duration were incomplete or unavailable. The source comorbidity field did not reliably distinguish chronic conditions from allergies and trauma-associated diagnoses, and contamination and foreign-body status were incompletely ascertained. The exploratory tests were unadjusted, involved correlated variables and sparse cells, and could not support causal inference.
This study complements the predominantly dog-bite-focused literature by describing a selected complicated subset across multiple mechanisms and by adding wound depth, initial closure, perioral anatomy, microbiology, and calendar-era management [
20,
21,
22,
23,
24,
25,
26]. Its contribution is a detailed description of actual conditions over 25 years and the identification of variables that future studies should capture consistently.
Future prospective multicenter studies should enroll all pediatric facial wounds; apply standardized infection, anatomical, depth, and closure definitions; prospectively record the surgeon/service, timing, debridement details, and antibiotic indication, route and duration; and ensure a sufficient sample size for adjusted analyses stratified by wound mechanism.
5. Conclusions
In this retrospective case series, 89 selected infected or delayed/non-recent records represented 0.36% of 24,877 pediatric facial-wound presentations. The wound mechanism, depth, anatomy, and management differed between the record-defined groups. Because of targeted retrospective ascertainment, heterogeneous documentation, and confounding by indication, the findings characterize a complicated clinical subset but do not estimate infection incidence or treatment effectiveness. Prospective multicenter studies with standardized definitions are needed to evaluate site-specific infection risk and treatment outcomes.
Author Contributions
Conceptualization, M.J. and S.P.; methodology, M.J. and S.P.; software, V.G., L.M.B., A.S., B.C., and S.P.; validation, V.G., L.M.B., A.S., and S.P.; formal analysis, M.J., V.G., L.M.B., A.S., B.C., and S.P.; investigation, M.J., V.G., L.M.B., A.S., B.C., and S.P.; resources, S.P.; data curation, V.G. and S.P.; writing—original draft preparation, V.G. and S.P.; writing—review and editing, M.J., V.G., L.M.B., A.S., B.C., and S.P.; visualization, V.G., L.M.B., A.S., and S.P.; supervision, S.P.; project administration, S.P. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Medical University of Vienna (protocol code 1133/2025; 11 March 2025).
Informed Consent Statement
Patient consent was waived due to the retrospective study design and the specifications given and approved by the corresponding ethics review board. No patients actively participated in this study. Patients were included after their entire treatment was finished.
Data Availability Statement
The datasets generated and/or analyzed in the current study are not publicly available due to data privacy but are available from the corresponding author on reasonable request.
Acknowledgments
During preparation of this manuscript, the authors used OpenAI ChatGPT (GPT-5; accessed 23 August 2026) for language editing, structural revision, and assistance with code used to verify descriptive calculations. The authors reviewed and independently verified all outputs against the source data and take full responsibility for the content of the publication. All authors included have consented to the acknowledgement.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- Dykes, E.H. Paediatric trauma. Br. J. Anaesth. 1999, 83, 130–138. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gao, H.; Li, Y.; Jin, S.; Zhai, W.; Gao, Y.; Pu, L. Epidemiological characteristics and factors affecting healing in unintentional pediatric wounds. Front. Public Health 2024, 12, 1352176. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shaikh, Z.S.; Worrall, S.F. Epidemiology of facial trauma in a sample of patients aged 1–18 years. Injury 2002, 33, 669–671. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gladitz, J.; Ribbecke, S. Durch Unfälle Hervorgerufene Kopfverletzungen bei Kindern im Häuslichen Bereich und Daran Beteiligte Produkte; DIN-Verbraucherrat: Berlin, Germany, 2017; p. 89. [Google Scholar]
- Fontana, S.; Schiestl, C.M.; Landolt, M.A.; Staubli, G.; von Salis, S.; Neuhaus, K.; Mohr, C.; Elrod, J. A Prospective Controlled Study on Long-Term Outcomes of Facial Lacerations in Children. Front. Pediatr. 2020, 8, 616151. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Thompson, R.; Wilkinson, M.; Combs, P.D.; Palomares, L.; Kienstra, A.J. Outcomes of Pediatric Facial Laceration Repair Using 5-0 Fast Absorbing Gut Sutures with and Without Overlying Adhesive Strips: A Randomized Controlled Trial. Pediatr. Emerg. Care. 2025, 41, 721–724. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Quinn, J.V.; Polevoi, S.K.; Kohn, M.A. Traumatic lacerations: What are the risks for infection and has the ‘golden period’ of laceration care disappeared? Emerg. Med. J. 2014, 31, 96–100. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- James, V.; Mohamad Ikbal, M.F.; Min, N.C.; Chan, Y.H.; Ganapathy, S. Periorbital Cellulitis in Paediatric Emergency Medicine Department Patients. Ann. Acad. Med. Singap. 2018, 47, 420–423. [Google Scholar] [CrossRef] [Scilit]
- Danishyar, A.; Sergent, S.R. Orbital Cellulitis. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2025. Available online: https://www.ncbi.nlm.nih.gov/books/NBK507901/ (accessed on 3 August 2026).
- Khatri, I.A.; Wasay, M. Septic cerebral venous sinus thrombosis. J. Neurol. Sci. 2016, 362, 221–227. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Peluso, H.; Vega, K.; Araya, S.; Talemal, L.; Moss, C.; Siegel, J.; Walchak, A. Incidence and characterization of facial lacerations in emergency departments in the United States. Craniomaxillofac. Trauma Reconstr. 2024, 17, NP113–NP120. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Chang, L.T.; Tsai, M.C. Craniofacial injuries from slip, trip, and fall accidents of children. J. Trauma 2007, 63, 70–74. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Albayatı, A.; Özkan, B.; Eyüboğlu, A.; Uysal, Ç.; Ertaş, N. A descriptive study of facial lacerations presenting to pediatric emergency care in Turkey. Turk. J. Trauma Emerg. Surg. 2021, 27, 61–66. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sun, H.; Yao, P.; Zitkovsky, H.; Tang, D.; Gao, Z.; Wang, X.; Xu, K.; Tao, A.; Tan, X. Epidemiological Investigation of Facial Soft Tissue Injury in Chinese Preschool Children. Ann. Plast. Surg. 2023, 90, S230–S233. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lee, J.H.; Jeon, M.S.; Lee, D.L.; Shin, H.K.; Seul, J.H. Analysis of patients with facial lacerations repaired in the emergency room of a provincial hospital. Arch. Plast. Surg. 2015, 42, 34–39. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Appelbaum, R.D.; Farrell, M.S.; Gelbard, R.B.; Hoth, J.J.; Jawa, R.S.; Kirsch, J.M.; Mandell, S.; Nohra, E.A.; Rinderknecht, T.; Rowell, S.; et al. Antibiotic prophylaxis in injury: An American Association for the Surgery of Trauma Critical Care Committee clinical consensus document. Trauma Surg. Acute Care Open 2024, 9, e001304. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Caruso, D.P.; Aquino, V.M.; Tannyhill, R.J.I.I.I. Algorithmic approach to antibiotic prophylaxis for traumatic craniomaxillofacial injuries. J. Craniofac. Surg. 2022, 33, 1082–1089. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Stevens, D.L.; Bisno, A.L.; Chambers, H.F.; Dellinger, E.P.; Goldstein, E.J.C.; Gorbach, S.L.; Hirschmann, J.V.; Kaplan, S.L.; Montoya, J.H.; Wade, J.C. Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2014, 59, 147–159. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Coyle, C.; Shi, J.; Leonard, J.C. Antibiotic prophylaxis in pediatric dog bite injuries: Infection rates and prescribing practices. J. Am. Coll. Emerg. Physicians Open 2024, 5, e13210. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Briotti, D.J.; Cransberg, D.J.; Chidambaram, D.R.; Nasim, D.S. A two-year retrospective cohort study investigating the occurrence and short-term outcomes of dog-bite injures in regional Western Australia. Injury 2024, 55, 111588. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mattice, T.; Schnaith, A.; Ortega, H.W.; Segura, B.; Kaila, R.; Amoni, I.; Shanley, R.; Louie, J.P. A Pediatric Level III Trauma Center Experience with Dog Bite Injuries. Clin. Pediatr. 2024, 63, 914–920. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Rohee-Traore, A.; Kahn, A.; Khonsari, R.H.; Pham-Dang, N.; Majoufre-Lefebvre, C.; Meyer, C.; Ferri, J.; Trost, O.; Poisbleau, D.; Kimakhe, J.; et al. Facial dog bites in children: A public health problem highlighted by COVID-19 lockdown. J. Stomatol. Oral Maxillofac. Surg. 2024, 125, 101671. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Truong, P.N.; Merlinsky, E.A.; Villatoro, G.A.; Mudie, L.I.; Yen, M.T.; Williams, K.J. Characterization, Epidemiology, and Outcomes of Periocular Dog Bites in Children. Ophthalmic Plast. Reconstr. Surg. 2026, 42, 189–195. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Waltman, E.M.; Mills, D.M.; Steidley, I.G.; Monuteaux, M.C.; Fleegler, E.W.; Kimia, A.A. Adherence to infection mitigation strategies for facial dog bite wounds: A retrospective analysis of a level 1 paediatric trauma centre. BMJ Paediatr. Open 2025, 9, e003616. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yu, Y.S.; Wang, L.Y.; Yang, S.W.; Wang, C.H. Choice of Primary Repair in Animal Bite Wound: A Novel Management Strategy. Int. Wound J. 2025, 22, e70761. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Jaindl, M.; Grünauer, J.; Platzer, P.; Endler, G.; Thallinger, C.; Leitgeb, J.; Kovar, F.M. The management of bite wounds in children–A retrospective analysis at a level I trauma centre. Injury 2012, 43, 2117–2121. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wilantho, A.; Deekaew, P.; Srisuttiyakorn, C.; Tongsima, S.; Somboonna, N. Diversity of bacterial communities on the facial skin of different age-group Thai males. PeerJ 2017, 5, e4084. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Raziyeva, K.; Kim, Y.; Zharkinbekov, Z.; Kassymbek, K.; Jimi, S.; Saparov, A. Immunology of Acute and Chronic Wound Healing. Biomolecules 2021, 11, 700. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zeng, Q.; Qi, X.; Shi, G.; Zhang, M.; Haick, H. Wound Dressing: From Nanomaterials to Diagnostic Dressings and Healing Evaluations. ACS Nano 2022, 16, 1708–1733. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Qi, X.; Li, Y.; Xiang, Y.; Chen, Y.; Shi, Y.; Ge, X.; Zeng, B.; Shen, J. Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers. Cell Biomater. 2025, 1, 100020. [Google Scholar] [CrossRef] [Scilit]
Table 1.
Operational record-based classification used in the analysis.
Table 1.
Operational record-based classification used in the analysis.
| Operational Group | Source-Record Rule | Interpretive Boundary |
|---|
| Record-coded clinically infected wound | The source-dataset infection indicator was coded yes, supported by clinician diagnosis or documentation of infection/inflammation. | Delay was not required, and no uniform prospective infection-severity scale was available. |
| Delayed/non-recent wound without record-coded infection | The source-dataset infection indicator was coded no and the clinical record described delayed or non-recent presentation. | Calendar dates did not contain time-of-day; a strict >24 h threshold could therefore not be verified retrospectively. |
Table 2.
Overall management, follow-up, and documented complications.
Table 2.
Overall management, follow-up, and documented complications.
| Parameter | Status | n | % | N |
|---|
| Surgery | No | 80 | 91 | 88 |
| | Yes | 8 | 9 | 88 |
| Hospital admission | No | 59 | 68 | 87 |
| | Yes | 28 | 32 | 87 |
| Microbiological testing | No | 78 | 89 | 88 |
| | Yes | 10 | 11 | 88 |
| Antibiotics before presentation | No | 83 | 94 | 88 |
| | Yes | 5 | 6 | 88 |
| Antibiotics after presentation | No | 33 | 38 | 86 |
| | Yes | 53 | 62 | 86 |
| Initial wound closure | No | 67 | 75 | 89 |
| | Yes | 22 | 25 | 89 |
| Complication | No | 79 | 94 | 84 |
| | Yes | 5 | 6 | 84 |
| Follow-up scheduled/required | No | 46 | 53 | 87 |
| | Yes | 41 | 47 | 87 |
Table 3.
Descriptive comparison of the two operational record-based groups.
Table 3.
Descriptive comparison of the two operational record-based groups.
| Characteristic | Infected n/Summary | % | N | Delayed n/Summary | % | N |
|---|
| Total | 61 | 69 | 89 | 28 | 31 | 89 |
| Age, years, median (IQR) | 4 (2–9) | | 61 | 4 (2–7.25) | | 28 |
| Sex | | | | | | |
| Female | 23 | 38 | 61 | 8 | 29 | 28 |
| Male | 38 | 62 | 61 | 20 | 71 | 28 |
| Injury type | | | | | | |
| Laceration | 42 | 69 | 61 | 21 | 75 | 28 |
| Dog bite | 8 | 13 | 61 | 0 | 0 | 28 |
| Human bite | 8 | 13 | 61 | 4 | 14 | 28 |
| Stab wound | 3 | 5 | 61 | 1 | 4 | 28 |
| Cut | 0 | 0 | 61 | 1 | 4 | 28 |
| Excoriation | 0 | 0 | 61 | 1 | 4 | 28 |
| Facial region | | | | | | |
| Frontal | 16 | 26 | 61 | 2 | 7 | 28 |
| Orbital | 11 | 18 | 61 | 5 | 18 | 28 |
| Forehead/periorbital | 27 | 44 | 61 | 7 | 25 | 28 |
| Oral | 13 | 21 | 61 | 16 | 57 | 28 |
| Buccal | 14 | 23 | 61 | 2 | 7 | 28 |
| Combined oral/buccal | 0 | 0 | 61 | 1 | 4 | 28 |
| Perioral | 27 | 44 | 61 | 19 | 68 | 28 |
| Nasal | 0 | 0 | 61 | 1 | 4 | 28 |
| Chin | 5 | 8 | 61 | 0 | 0 | 28 |
| Auricular | 1 | 2 | 61 | 1 | 4 | 28 |
| Other | 1 | 2 | 61 | 0 | 0 | 28 |
| Wound depth | | | | | | |
| Superficial | 16 | 26 | 61 | 20 | 71 | 28 |
| Subcutaneous | 28 | 46 | 61 | 7 | 25 | 28 |
| Intramuscular | 15 | 25 | 61 | 0 | 0 | 28 |
| Unknown | 2 | 3 | 61 | 1 | 4 | 28 |
| Initial wound management | | | | | | |
| Initial closure: yes | 16 | 26 | 61 | 6 | 21 | 28 |
| Steri-Strips | 3 | 19 | 16 | 3 | 50 | 6 |
| Suture | 10 | 63 | 16 | 3 | 50 | 6 |
| Other technique | 2 | 13 | 16 | 0 | 0 | 6 |
| Tissue adhesive | 1 | 6 | 16 | 0 | 0 | 6 |
| Perioral subgroup | | | | | | |
| External | 15 | 68 | 22 | 7 | 39 | 18 |
| Intraoral | 6 | 27 | 22 | 11 | 61 | 18 |
| External and intraoral | 1 | 5 | 22 | 0 | 0 | 18 |
| Vermilion involved | 7 | 26 | 27 | 5 | 26 | 19 |
| Intraoral self-bite | 11 | 58 | 19 | 9 | 60 | 15 |
| Intraoral laceration | 8 | 42 | 19 | 6 | 40 | 15 |
| Management/outcomes | | | | | | |
| Hospital admission: yes | 26 | 44 | 59 | 2 | 7 | 28 |
| Surgery: yes | 8 | 13 | 60 | 0 | 0 | 28 |
| Microbiology: yes | 9 | 15 | 60 | 1 | 4 | 28 |
| Antibiotics before presentation: yes | 5 | 8 | 60 | 0 | 0 | 28 |
| Antibiotics after presentation: yes | 48 | 83 | 58 | 5 | 18 | 28 |
| Complication: yes | 5 | 9 | 56 | 0 | 0 | 28 |
Table 4.
Exploratory associations with record-coded infected-group membership.
Table 4.
Exploratory associations with record-coded infected-group membership.
| Characteristic | Infected Yes/N (%) | Delayed Yes/N (%) | OR (95% CI) | Fisher p |
|---|
| Forehead/periorbital | 27/61 (44) | 7/28 (25) | 2.38 (0.88–6.43) | 0.103 |
| Perioral | 27/61 (44) | 19/28 (68) | 0.38 (0.15–0.96) | 0.043 |
| Any bite | 16/61 (26) | 4/28 (14) | 2.13 (0.64–7.10) | 0.279 |
| Dog bite | 8/61 (13) | 0/28 (0) | Not estimable | 0.053 |
| Subcutaneous/intramuscular depth | 43/59 (73) | 7/27 (26) | 7.68 (2.73–21.61) | <0.001 |
| Initial closure | 16/61 (26) | 6/28 (21) | 1.30 (0.45–3.79) | 0.793 |
| Hospital admission | 26/59 (44) | 2/28 (7) | 10.24 (2.22–47.17) | <0.001 |
| Antibiotics after presentation | 48/58 (83) | 5/28 (18) | 22.08 (6.76–72.07) | <0.001 |
Table 5.
Post hoc descriptive sensitivity analysis by calendar era.
Table 5.
Post hoc descriptive sensitivity analysis by calendar era.
| Era | n | Infected n (%) | Delayed n (%) | Antibiotics After Presentation Yes/N (%) | Admission Yes/N (%) | Surgery Yes/N (%) |
|---|
| 2000–2007 | 30 | 29 (97) | 1 (3) | 23/29 (79) | 12/29 (41) | 6/29 (21) |
| 2008–2015 | 34 | 15 (44) | 19 (56) | 14/34 (41) | 8/34 (24) | 2/34 (6) |
| 2016–2024 | 25 | 17 (68) | 8 (32) | 16/23 (70) | 8/24 (33) | 0/25 (0) |
| Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |